Term
|
Definition
mechloroethamine, anthracyclines |
|
|
Term
IV, Intra-arterial, Intrathecally and oral administration routs |
|
Definition
|
|
Term
IV and oral administration |
|
Definition
cyclophosfamide, epipodopyllotoxins (oral is only 50% bioavail) |
|
|
Term
prevents multidrug resistance in tumor seen with anthracyclines |
|
Definition
verapamil; inhibits active transport by inhibiting ATP binding causing a dysfunctional pump |
|
|
Term
irreversible cardiotoxicity |
|
Definition
doxorubacin, daunorubacin |
|
|
Term
metal chelating agent that binds Fe/OH product used to mitigate anthracycling-associated cardiotoxicity |
|
Definition
|
|
Term
Used to treat mitomycin-induced Hemolytic-uremic syndrome |
|
Definition
catopril, heparin and prednisone |
|
|
Term
FH2 rescue after high dose methotrexate |
|
Definition
|
|
Term
6-MP-induced hyperuricemia |
|
Definition
lower dose and add allopurinol, no dose adjustment for 6-TG |
|
|
Term
|
Definition
mechloroethamine, anthracyclines (mitoxantrone less so), mitomycin, and vinca alkaloids |
|
|
Term
albumin-bound paclitaxel dosage form option for taxane-induced HS |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
cisplatin/ carboplatin and methotrexate (precipitation of 7OH metabolite) |
|
|
Term
|
Definition
|
|
Term
|
Definition
doxorubacin (daunorubacin), carboplatin |
|
|
Term
|
Definition
methotrexate, cytarabine, 6-MP (6-TG less so) |
|
|
Term
|
Definition
|
|
Term
|
Definition
alkylating agents and cisplatin |
|
|
Term
|
Definition
antimetabolites, except 5-FU |
|
|
Term
|
Definition
non-phase specific because it acts on both the DNA and RNA |
|
|
Term
|
Definition
|
|
Term
cell cycle non-specific but maximal kill in G1 and S-phase |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
taxanes; paclitaxel and docetaxel |
|
Definition
|
|
Term
|
Definition
metabolite of CTP-11 (irinotecan) that is 1000-fold more potent, if there is mutation in conjugation step of metabolism this metabolite is not excreted causing toxicity |
|
|